Novo’s New Obesity Drug Is Targeting the Most Dramatic Weight Loss Yet
The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a ...
A new weight loss drug could beat Ozempic's side effect problem
The Denmark-based drug maker Zealand Pharma said Tuesday that its experimental weight-loss drug could help patients lose ...
Zealand’s Weight-Loss Drug Has Minimal Side Effects in Study
Zealand Pharma A/S said moderate doses of its experimental weight-loss drug helped patients pare pounds with less nausea than ...
Microdosing Ozempic? Why some people are playing doctor with weight-loss drugs
Some patients are using lower-than-recommended dosages of generic weight-loss drugs to slim down ... As powerful anti-obesity ...
As Race To Best 'Miracle' Obesity Drug Heats Up, Ozempic Maker Novo Nordisk Tests New Hybrid Drug That Can Reduce Weight Up To 25%
Novo's development chief, Martin Holst Lange, has shown optimism about the drug's promise, though he refrained from making ...
Medscape5d
Weight Loss Surgery, Obesity Drugs Achieve Similar Results but Have Different Safety Profiles
PHILADELPHIA — Roux-en-Y gastric bypass (RYGB) produces maximal weight loss in patients with obesity compared with other ...
Nature18h
How ‘miracle’ weight-loss drugs will change the world
Welcome to the healthier, happier world of 2030. Heart attacks and strokes are down 20%. A drop in food consumption has left ...
Yahoo Finance21d
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win
but said that it is the company’s separate obesity drug candidate — Petrelintide, a long-acting amylin analog — that could set it apart in the weight-loss drug segment.
Newsweek22d
Teens With Obesity Less Likely to Be Suicidal on Weight Loss Drugs: Study
Teenagers with obesity ... a new study published on Monday. More fizkes / aprott/Getty Images / Canva Doctors have previously expressed concerns over young people taking GLP-1 weight loss drugs.